Clinical Trials Logo

Oligodendroglioma, Adult clinical trials

View clinical trials related to Oligodendroglioma, Adult.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT00003472 Terminated - Clinical trials for Oligodendroglioma, Adult

Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Oligodendroglioma

Start date: May 1996
Phase: Phase 2
Study type: Interventional

RATIONALE: Current therapies for adult recurrent/progressive oligodendrogliomas provide very limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of childhood brain tumors. PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on adult recurrent/progressive oligodendrogliomas.